SavedAdd your journal

Journals / Journal of Contemporary Medicine / 2025 / Cilt: 15 Sayı: 1

Effect of Surfactant Protein B and D Genes Polymorphisms on Frequency and Severity of Acute Bronchiolitis

Surfaktan Protein B ve D Gen Polimorfizmlerinin Akut Bronşiolitin Sıklık ve Şiddeti Üzerine Etkileri

Buket Altıntaş Seyyah
Ali Gül
Şahin Takçı
Hacı Ömer Ateş
Resul Yılmaz
Pages
1–5
Publication Date
2025-01-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early identification of children at risk could enable close monitoring and preventive care.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and aim: Acute bronchiolitis (AB) is the most common cause of hospitalization in infants.
📊
Key Findings & Data:Materials and Methods: The study included 106 infants diagnosed with AB and 107 healthy infants recruited from a pediatric outpatient clinic.
💡
Conclusion & Impact:Early identification of children at risk could enable close monitoring and preventive care.
🔬Design:Text.Serial.Journal
📍Scope:Comprehensive Sample
⚙️Variables:akut bronşiolit · surfaktan protein · polimorfizm

Abstract

Background and aim: Acute bronchiolitis (AB) is the most common cause of hospitalization in infants. Varying bronchiolitis presentations in patients with similar demographic characteristics suggest genetic causes of individual differences. Materials and Methods: The study included 106 infants diagnosed with AB and 107 healthy infants recruited from a pediatric outpatient clinic. Genotyping was conducted for intron 4 and C/A–18 in the SP-B gene, along with SP-D/160 (Ala160Thr) and SP-D/270 (Ser270Thr) polymorphisms in the SP-D gene. Results: The SP-B intron 4 invariant polymorphisms of ins/ins and ins/del were 93.40% and 4.72% in the AB group and 84.11% and 15.89% in the control group, respectively (p = 0.012). Frequency of polymorphism in the SP-D/270 (Ser270Thr) gene for Ser/Ser and Ser/Thr was 60% and 39.05% in the AB group and 79.44% and 18.69% in the control group, respectively (p = 0.004). The frequencies of Ser and Thr alleles were 79.90% and 20.10% in the AB group and 88.79% and 11.21% in the control group, respectively (p = 0.012). There was no observed correlation between the SP-B intron 4 and C/A-1, as well as the SP-D Ser270Thr and Ala160Thr polymorphisms, with the severity of AB (p > 0.05). Conclusion: SP-B gene polymorphisms were identified as risk factors for AB, while SP-D polymorphisms appeared to play a protective role. However, these polymorphisms were not linked to AB severity. Early identification of children at risk could enable close monitoring and preventive care.

Özet

Giriş ve Amaç: Akut bronşiolit (AB), infantlarda en yaygın hastaneye yatış nedenidir. Benzer demografik özelliklere sahip hastalar arasında bronşiolitin farklı şekilde seyretmesi, bireysel farklılıklarda genetik faktörlerin rol oynayabileceğini düşündürmektedir. Yöntem ve Gereç: Çalışmaya bir çocuk polikliniğinden alınan, AB tanısı almış 106 bebek ve sağlıklı 107 bebek dahil edilmiştir. SP-B genindeki intron 4 ve C/A–18, ayrıca SP-D genindeki SP-D/160 (Ala160Thr) ve SP-D/270 (Ser270Thr) polimorfizmleri için genotipleme yapılmıştır. Bulgular: SP-B intron 4 sabit polimorfizmleri olan ins/ins ve ins/del oranları, AB grubunda sırasıyla %93,40 ve %4,72, kontrol grubunda ise %84,11 ve %15,89 olarak bulunmuştur (p = 0,012). SP-D/270 (Ser270Thr) genindeki Ser/Ser ve Ser/Thr polimorfizmleri AB grubunda %60 ve %39,05, kontrol grubunda ise %79,44 ve %18,69 oranında tespit edilmiştir (p = 0,004). Ser ve Thr allel frekansları AB grubunda sırasıyla %79,90 ve %20,10, kontrol grubunda ise %88,79 ve %11,21 olarak belirlenmiştir (p = 0,012). SP-B intron 4, C/A–18 ile SP-D Ser270Thr ve Ala160Thr polimorfizmleri ile AB’nin şiddeti arasında herhangi bir ilişki bulunmamıştır (p > 0,05). Sonuç: SP-B gen polimorfizmleri, AB için bir risk faktörü olarak belirlenirken, SP-D polimorfizmleri koruyucu bir rol oynamaktadır. Bununla birlikte, bu polimorfizmler AB’nin şiddeti ile ilişkili bulunmamıştır. Risk altındaki çocukların önceden tespit edilmesi ve yakından izlenmesi AB morbiditesi açısından önemli olabilir.

🔖

Cite This Article

Seyyah, B. A., Gül, A., Takçı, Ş., Ateş, H. Ö., Yılmaz, R. (2025). Effect of Surfactant Protein B and D Genes Polymorphisms on Frequency and Severity of Acute Bronchiolitis. Journal of Contemporary Medicine, Cilt: 15 Sayı: 1, 1–5. https://doi.org/10.16899/jcm.1605226

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bria M, Coates LEC. Wheezing in Infants: Bronchiolitis, in Nelson Textbook of Pediatrics, Kliegman RM, Editor. Elsevier: Canada. 2016;2044-50
  2. Gul A, Takçı Ş, Altıntaş Seyyah B, Yılmaz R. Independent Predictorsof Severity and Hospitalization in Acute Bronchiolitis: Neutrophil/Lymphocyte Ratio and Mean Platelet Volume. J Pediatr Infect Dis2018;13(04):268-73
  3. Yusen RD, Cohen AH, Hamvas A. Normal lung function in subjects heterozygous for surfactant protein-B deficiency. Am J Respir Crit Care Med. 1999;159(2):411-4
  4. Tokieda K, Iwamoto HS, Bachurski C, et al. Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol. 1999;21(4):463-72
  5. Tokieda K, Whitsett JA, Clark JC, et al. Pulmonary dysfunction in neonatal SP-B-deficient mice. Am J Physiol. 1997;273(4):875-82
  6. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5(1):58-68
  7. Hamvas A. Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation. Semin Perinatol. 2006;30(6):316-26
  8. Kültürsay N, Uygur Ö, Yalaz M. Yenidoğan döneminde sürfaktan kullanımı-bilinenler, halen araştırılanlar, araştırılması gerekenler. Türk Ped Arş 2014;49:1-12
  9. Weaver TE, Whitsett JA. Function and regulation of expression of pulmonary surfactant-associated proteins. Biochem J. 1991;273(Pt 2)(Pt 2):249-64
  10. Mallory GB Jr. Surfactant proteins: role in lung physiology and disease in early life. Paediatr Respir Rev. 2001;2(2):151-8
  11. Cole FS, Hamvas A, Nogee LM. Genetic disorders of neonatal respiratory function. Pediatr Res. 2001;50(2):157-62
  12. Ventre K, Haroon M, Davison C. Surfactant therapy for bronchiolitis in critically ill infants. Cochrane Database Syst Rev. 2006;(3):CD005150
  13. Davison C, Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and metaanalysis. Pediatr Crit Care Med. 2004;5(5):482-9
  14. Hallman M, Haataja R. Surfactant protein polymorphisms and neonatal lung disease. Semin Perinatol. 2006;30(6):350-61
  15. Sorensen GL. Surfactant Protein D in Respiratory and Non-Respiratory Diseases. Front Med (Lausanne). 2018;5:18
  16. Hartshorn KL, Crouch E, White MR, et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol. 1998;274(6):958-69
  17. LeVine AM, Elliott J, Whitsett JA, et al. Surfactant protein-d enhances phagocytosis and pulmonary